Showing results (121-130 of 15,777) with videos related to
Sort By:
Pageof 1,578
Cancer|March 1, 1977
Tumor growth patterns in multiple myelomaJ A Hokanson, B W Brown, J R Thompson, et al.Cancer Treatment Reports|March 1, 1984
Addition of cisplatin and bleomycin to vincristine-carmustine-doxorubicin-prednisone (VBAP) combination in the treatment of relapsing or resistant multiple myeloma: a Southwest Oncology Group studyJ D Bonnet, R Alexanian, S E Salmon, et al.The Journal of Clinical Investigation|September 1, 1983
Marrow cytometry and prognosis in myelomaB Barlogie, R Alexanian, E A Gehan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
Adjuvant therapy with escalating doses of doxorubicin and cyclophosphamide with or without leukocyte alpha-interferon for stage II or III breast cancerA U Buzdar, G N Hortobagyi, S W Kau, et al.Investigational New Drugs|May 10, 2023
Epigenetic modifiers either individually or in specific combinations impair viability of patient-derived glioblastoma cell line while exhibit moderate effect on normal stem cells growthArshak R Alexanian, Heidi Marie Stoellinger, Virginea de Araujo Farias, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1987
Local infusion of urokinase for the lysis of thrombosis associated with permanent central venous catheters in cancer patientsG Fraschini, J Jadeja, M Lawson, et al.Radiology|November 1, 1994
Multiple myeloma: MR patterns of response to treatmentL A Moulopoulos, M A Dimopoulos, R Alexanian, et al.Bone Marrow Transplantation|December 10, 2013
Value of novel agents and intensive therapy for patients with multiple myelomaR Alexanian, M Wang, K Delasalle, et al.International Journal of Cancer|October 23, 1997
Secondary drug resistance in breast cancer: failure to reverse with oral nifedipineF A Holmes, A Lopez, G Mavligit, et al.Cancer|March 15, 1997
Chemotherapy-induced neutropenia and fever in patients with metastatic breast carcinoma receiving salvage chemotherapyZ Rahman, L Esparza-Guerra, H Y Yap, et al.Pageof 1,578